Sign in
Taking people in United StatesEarly phase 1

Imaging Mitochondrial Complex-I in Alcohol Use Disorder

Key facts

Who runs it
Rajesh Narendran
Where
Pittsburgh, United StatesSee the site
Trial code
Status
Recruiting
Phase
Early phase 1
People taking part
100 people, planned
Started
30 Sept 2026
Expected to end
31 Dec 2032
Type of study
Interventional
Treatments tested
  • [F-18]BCPP-EF
  • [F-18]FDG
Record updated
3 November 2026

Who can take part

Age
18 years to 55 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 15 criteriaShow less

Other criteria

  • Alcohol use disorders (AUD)
  • Males or females between 18 and 55 years old
  • fulfill DSM-5 criteria for alcohol use disorder
  • History of NIAAA heavy drinking (for males, routinely consuming more than 4 drinks on any day or more than 14 drinks per week; for females, routinely consuming more than 3 drinks on any day or more than 7 drinks per week) in the past 30 days
  • No other major DSM-5 psychiatric disorders including schizophrenia, schizoaffective disorder, bipolar disorder, developmental disorders, or current depressive disorders (unless they are related to alcohol intoxication, withdrawal, or an alcohol- induced mood disorder)
  • No other DSM-5 substance use disorders including opioids, cocaine, amphetamines, sedative-hypnotics, hallucinogens, and inhalants. Subjects with moderate and severe DSM-5 cannabis and tobacco use disorder will also be excluded
  • Subjects not currently on psychotropic or medical medications that can influence binding to MC-I (e.g., metformin) or CGM (e.g., insulin, GLP-1 agonists), or increase the risks associated with an arterial line (e.g., warfarin, clopidogrel, aspirin, naproxen, ibuprofen, etc.)
  • No medical disorders that can influence the PET outcome measures (for example, MC-I binding is altered in Parkinson's disease, mild or major neurocognitive disorders, and mitochondrial disorders; CGM is altered in diabetes, severe hyperlipidemia, hypertension, obesity), increase the risks associated with blood sampling (anemia), or placement of an arterial line (history of deep vein thrombosis, pulmonary embolism, thrombocytopenia or thrombocytosis) for PET
  • Not currently pregnant or breast-feeding
  • Not currently employed as a radiation worker; or has participated in a radiation-related research protocol within the previous year such that the total cumulative annual radiation dose (i.e., from participation in the previous radioactive drug study [studies] and this study) would exceed the radiation dose limits specified in the FDA regulations (i.e., 21 CFR 361.1) that govern the research use of radiotracers
  • No medical or psychiatric contraindications to undergo an MRI scan (such as ferromagnetic tattoos/piercings, implants, medical equipment, history of gunshot, and claustrophobia); Healthy controls (HC)
  • Males or females between 18 and 55 years old
  • No current or past DSM-5 psychiatric or substance use disorders other than tobacco use disorder
  • No history of heavy drinking as defined using NIAAA criteria in the past year
  • 5 to 10 above

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 55 years old?

Where in United States

  • University of PittsburghPittsburgh, United StatesContact: Principal InvestigatorTaking people

About the trial

What the trial wants to find out

Studies proposed in this application will image mitochondrial Complex-I (MCI-I) and cerebral glucose metabolism (CGM) in alcohol use disorder (AUD) and matched healthy controls

The group in the trial

  • PETTreatment being tested

    Positron Emission Tomography Scans

    Treatment: [F-18]BCPP-EF and [F-18]FDG

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Imaging Mitochondrial Complex-I With [F-18]BCPP-EF Positron Emission Tomography (PET) in Alcohol Use Disorder (AUD)
Criteria questions
Built from NCT07825818, who can take part
Record updated
3 November 2026